Tag: #DiabeticKidneyDisease
-
SGLT2 Inhibitors and Nephroprotection Advancing Treatment for Diabetic Kidney Disease
Introduction: Diabetic kidney disease (DKD) remains a leading cause of end-stage renal failure worldwide, contributing significantly to morbidity and mortality in individuals with Type 2 Diabetes Mellitus (T2D). Recent advancements highlight the potential of sodium-glucose cotransporter-2 (SGLT2) inhibitors as a groundbreaking therapeutic approach. These drugs not only regulate blood glucose levels but also provide nephroprotective…
-
PTM-Fetuin-A A Novel Biomarker for Early Detection of Diabetic Kidney Disease
Introduction Chronic Kidney Disease (CKD) is a significant global health concern, with diabetic kidney disease (DKD) being one of its leading causes. Early detection is crucial to prevent progression to End-Stage Renal Disease (ESRD), yet traditional biomarkers like serum creatinine and estimated glomerular filtration rate (eGFR) have notable limitations. Emerging research highlights PTM-Fetuin-A as a…
Heighten Science Publications Inc. 